Does RIBOCICLIB Cause Gait inability? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Gait inability have been filed in association with RIBOCICLIB (KISQALI). This represents 0.4% of all adverse event reports for RIBOCICLIB.
122
Reports of Gait inability with RIBOCICLIB
0.4%
of all RIBOCICLIB reports
16
Deaths
45
Hospitalizations
How Dangerous Is Gait inability From RIBOCICLIB?
Of the 122 reports, 16 (13.1%) resulted in death, 45 (36.9%) required hospitalization, and 8 (6.6%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which RIBOCICLIB Alternatives Have Lower Gait inability Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN